Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment. - Test2 - elhamkhani - TriplyDB

Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment.

Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment.

http://www.wikidata.org/entity/Q33389387

about

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation.

P2860

Q38200909-E1B1CFA4-F56A-493F-B3DC-479E4B6276A9

P2860

Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment.

http://www.wikidata.org/entity/Q33389387

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Priming with r-metHuSCF and fi ...... mobilization and engraftment.

@ast

Priming with r-metHuSCF and fi ...... mobilization and engraftment.

@en

type

label

Priming with r-metHuSCF and fi ...... mobilization and engraftment.

@ast

Priming with r-metHuSCF and fi ...... mobilization and engraftment.

@en

prefLabel

Priming with r-metHuSCF and fi ...... mobilization and engraftment.

@ast

Priming with r-metHuSCF and fi ...... mobilization and engraftment.

@en

P1433

Q33389387-AE5BC1DD-BC6F-4B03-BED5-EC7B51C8D24D

P1476

Q33389387-488AFA9E-0F39-4294-85A1-E04FB7646CD6

P2093

Q33389387-020B59F5-349B-4E29-9DE5-3D290D1D9986

Q33389387-0D84B2E3-2BBA-45E5-B9C2-1DCC1D04744A

Q33389387-4B812960-96F5-4AEC-920E-F41E4E2A443E

Q33389387-610DEE33-1614-4A87-AFEF-21444C8D4265

Q33389387-84FF738F-7D86-4E16-9CF5-146CD02D6BDB

Q33389387-8E2FD12D-2F46-4F84-B97C-DF46F581F45F

Q33389387-8E7E05C5-1090-41BA-A1D3-419395CB34EF

Q33389387-8FA612B4-5011-4326-B08C-BA8430D7F199

Q33389387-A941E1DC-8DB5-483C-A0DA-2937CFAE86BF

Q33389387-CAE64CD9-559B-4CEA-BDFE-A9DAC36FAC39

P2860

Q33389387-2C1DC845-3EAA-44FC-9126-DB3E0EB79F41

Q33389387-8C2B31A6-FB67-4BD3-BBA0-2060777941BC

Q33389387-935D0E26-9800-43DD-9DFE-C37FBEFA5E90

Q33389387-9882192A-DA15-4CD3-8783-BAF7F1FCC322

Q33389387-A18AA1CB-611D-4B91-9A70-D5547A9FF3AD

Q33389387-A5230F59-DB0F-43CE-A01D-7FEEE62D1204

Q33389387-E967C757-374E-4705-B95C-0B4EA5CF6007

Q33389387-F5607A03-89B5-4517-B25A-4FEFC63472DA

P2888

Q33389387-3C088AA0-58F8-4D55-90B0-28156C9E7D71

P304

Q33389387-BD0291EB-0A76-43E8-83A8-6AF798013598

P31

Q33389387-A3A5E69B-AFF1-435C-9101-5084A5974A9C

P356

Q33389387-F8574579-BA65-43EC-B14E-535EA6F49B09

P407

Q33389387-A71132EA-E375-4F10-81CC-BCB17620D356

P433

Q33389387-20F5CF62-D8D8-45CE-A76D-CD1428729355

P478

Q33389387-C9B44CE0-00D6-40FD-AEF7-FAD773E6C2F7

P50

Q33389387-C510EA3A-AB96-4EE2-A70F-A96567AEACE1

P577

Q33389387-E8AC3D0C-0292-4F1A-806D-DBC0472F6C17

P5875

Q33389387-8B8441D1-763E-4EE7-9EEE-33106D068947

P6179

Q33389387-800E88CE-5D75-4475-BA6A-9149BD9C7E77

P698

Q33389387-8ECD0A2A-70F6-4019-A9EE-543C73AD05F9

P356

P1433

Bone Marrow Transplantation

P1476

Priming with r-metHuSCF and fi ...... mobilization and engraftment.

@en

P2093

A Schmitz

http://www.w3.org/2001/XMLSchema#string

C Geisler

http://www.w3.org/2001/XMLSchema#string

E Juvonen

http://www.w3.org/2001/XMLSchema#string

G Juliusson

http://www.w3.org/2001/XMLSchema#string

G Kvalheim

http://www.w3.org/2001/XMLSchema#string

G W Jürgensen

http://www.w3.org/2001/XMLSchema#string

K Remes

http://www.w3.org/2001/XMLSchema#string

L M Pedersen

http://www.w3.org/2001/XMLSchema#string

M Boegsted

http://www.w3.org/2001/XMLSchema#string

O J Bergmann

http://www.w3.org/2001/XMLSchema#string

P2860

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial.

Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories.

Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells.

A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF.

Stem cell factor leads to reduced blood processing during apheresis or the use of whole blood aliquots to support dose-intensive chemotherapy.

Evaluation of mobilized CD34+ cell counts to guide timing and yield of large-scale collection by leukapheresis.

A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts.

P2888

P304

44-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2010.84

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

Hans Erik Johnsen

P577

2010-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43535462

http://www.w3.org/2001/XMLSchema#string

P6179

1005962975

http://www.w3.org/2001/XMLSchema#string

P698

20436517

http://www.w3.org/2001/XMLSchema#string